{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:50:18Z","timestamp":1789494618700,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>X-linked agammaglobulinaemia (XLA) is a rare inherited primary immunodeficiency disease characterized by the B cell developmental defect, caused by mutations in the gene coding for Bruton\u2019s tyrosine kinase (BTK), which may cause serious recurrent infections. The diagnosis of XLA is sometimes challenging because a few number of patients have higher levels of serum immunoglobulins than expected. In this study, we reported an atypical case with recurrent meningitis, delayed diagnosis with XLA by genetic analysis at the second episode of meningitis at the age of 8 years.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case report<\/jats:title>\n<jats:p>An 8-year-old Chinese boy presented with fever, dizziness and recurrent vomiting for 3 days. The cerebrospinal fluid (CSF) and magnetic resonance imaging (MRI) results were suggestive of bacterial meningoencephalitis, despite the negative gram staining and cultures of the CSF. The patient was treated with broad-spectrum antibiotics and responded well to the treatment. He had history of another episode of acute pneumococci meningitis 4 years before. The respective level of Immunoglobulin G (IgG), Immunoglobulin A (IgA) and Immunoglobulin M (IgM) was 4.85\u2009g\/L, 0.93\u2009g\/L and 0.1\u2009g\/L at 1<jats:sup>st<\/jats:sup> episode, whereas 1.9\u2009g\/L, 0.27\u2009g\/L and 0\u2009g\/L at second episode. The B lymphocytes were 0.21 and 0.06% of peripheral blood lymphocytes at first and second episode respectively. Sequencing of the <jats:italic>BTK<\/jats:italic> coding regions showed that the patient had a point mutation in the intron 14, hemizyous c.1349\u2009+\u20095G\u2009&gt;\u2009A, while his mother had a heterozygous mutation. It was a splice site mutation predicted to lead to exon skipping and cause a truncated BTK protein.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Immunity function should be routinely checked in patients with severe intracranial bacterial infection. Absence of B cells even with normal level of serum immunoglobulin suggests the possibility of XLA, although this happens only in rare instances. Mutational analysis of <jats:italic>BTK<\/jats:italic> gene is crucial for accurate diagnosis to atypical patients with XLA.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12883-019-1536-7","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T14:44:23Z","timestamp":1576507463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Delayed diagnosis of X-linked agammaglobulinaemia in a boy with recurrent meningitis"],"prefix":"10.1186","volume":"19","author":[{"given":"Ya-Ni","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Da","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-Bin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Lu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9076-2006","authenticated-orcid":false,"given":"Wen-Xiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"1536_CR1","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","volume":"35","author":"C Picard","year":"2015","unstructured":"Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency. J Clin Immunol. 2015;35:696\u2013726.","journal-title":"J Clin Immunol"},{"key":"1536_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley ME. NotarangeloLD, EtzioniA. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93:190\u20137.","journal-title":"Clin Immunol"},{"key":"1536_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1006\/clim.2002.5241","volume":"104","author":"A Plebani","year":"2002","unstructured":"Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, Cardinale F, et al. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia:an Italian multicenter study. Clin Immunol. 2002;104:221\u201330.","journal-title":"Clin Immunol"},{"key":"1536_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/1744666X.2018.1413349","volume":"14","author":"E Carrillo-Tapia","year":"2018","unstructured":"Carrillo-Tapia E, Garc\u00eda-Garc\u00eda E, Herrera-Gonz\u00e1lez NE, Yamazaki-Nakashimada MA, Staines-Boone AT, Segura-Mendez NH, et al. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains. Expert Rev Clin Immunol. 2018;14:83\u201393.","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"1536_CR5","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1067\/mai.2001.120133","volume":"108","author":"H Kanegane","year":"2001","unstructured":"Kanegane H, Futatani T, Wang Y, Nomura K, Shinozaki K, Matsukura H, Kubota T, Tsukada S, Miyawaki T. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis. J Allergy Clin Immunol. 2001;108(6):1012\u201320.","journal-title":"J Allergy Clin Immunol"},{"key":"1536_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/hmg\/4.1.51","volume":"4","author":"I Vorechovsk\u00fd","year":"1995","unstructured":"Vorechovsk\u00fd I, Vihinen M, de Saint BG, Honsov\u00e1 S, Hammarstr\u00f6m L, M\u00fcller S, et al. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia. Hum Mol Genet. 1995;4:51\u20138.","journal-title":"Hum Mol Genet"},{"key":"1536_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10875-008-9227-y","volume":"29","author":"N Basile","year":"2009","unstructured":"Basile N, Danielian S, Oleastro M, Rosenzweig S, Prieto E, Rossi J, et al. Clinical and molecular analysis of 49 patients with X-linked agammaglobulinemia from a single center in Argentina. J Clin Immunol. 2009;29:123\u20139.","journal-title":"J Clin Immunol"},{"key":"1536_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/(SICI)1098-1004(1999)13:4<280::AID-HUMU3>3.0.CO;2-L","volume":"13","author":"M Vihinen","year":"1999","unstructured":"Vihinen M, Kwan SP, Lester T, Ochs HD, Resnick I, V\u00e4liaho J, Conley ME, Smith CI. Mutations of the human BTK gene coding for bruton tyrosine kinase in X-linked agammaglobulinemia. Hum Mutat. 1999;13:280\u20135.","journal-title":"Hum Mutat"},{"key":"1536_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1189\/jlb.0513307","volume":"95","author":"G L\u00f3pez-Herrera","year":"2014","unstructured":"L\u00f3pez-Herrera G, Vargas-Hern\u00e1ndez A, Gonz\u00e1lez-Serrano ME, Berr\u00f3n-Ruiz L, Rodr\u00edguez-Alba JC, Espinosa-Rosales F. Bruton's tyrosine kinase--an integral protein of B cell development that also has an essential role in the innate immune system. J Leukoc Biol. 2014;95:243\u201350.","journal-title":"J Leukoc Biol"},{"key":"1536_CR10","doi-asserted-by":"publisher","first-page":"e4544","DOI":"10.1097\/MD.0000000000004544","volume":"95","author":"XF Chen","year":"2016","unstructured":"Chen XF, WangWF ZYD, Zhao W, Wu J, Chen TX. Clinical characteristics and genetic profiles of 174 patients with X-linked agammaglobulinemia: Report from Shanghai, China (2000\u20132015). Medicine (Baltimore). 2016;95:e4544.","journal-title":"Medicine (Baltimore)"},{"key":"1536_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.bcmd.2010.01.004","volume":"44","author":"K Maekawa","year":"2010","unstructured":"Maekawa K, Yamada M, Okura Y, Sato Y, Yamada Y, Kawamura N, et al. X-linked agammaglobulinemia in a 10-year-old boy with a novel non-invariant splice-site mutation in Btk gene. Blood Cells Mol Dis. 2010;44:300\u20134.","journal-title":"Blood Cells Mol Dis"},{"key":"1536_CR12","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.4049\/jimmunol.167.7.4038","volume":"67","author":"EK Jo","year":"2001","unstructured":"Jo EK, Kanegane H, Nonoyama S, Tsukada S, Lee JH, Lim K, et al. Characterization of mutations, including a novel regulatory defect in the first intron, in Bruton's tyrosine kinase gene from seven Korean X-linked agammaglobulinemiafamilies. J Immunol. 2001;67:4038\u201345.","journal-title":"J Immunol"},{"key":"1536_CR13","first-page":"65","volume":"46","author":"B Duriez","year":"1994","unstructured":"Duriez B, Duquesnoy P, Dastot F, Bougn\u00e8res P, Amselem S, Goossens M. An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency. FEBS Lett. 1994;46:65\u201370.","journal-title":"FEBS Lett"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1536-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-019-1536-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1536-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:15:43Z","timestamp":1607645743000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-019-1536-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1536"],"URL":"https:\/\/doi.org\/10.1186\/s12883-019-1536-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"13 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research protocol was approved by the Institutional Review Board of the Guangzhou Women and Children\u2019s Medical Center.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents were obtained from the parent for the publication of all the personal and medical information included in the case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"320"}}